SBRA - Sabra Health Care REIT, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$22.50
DETAILS
HIGH:
$25.00
LOW:
$21.00
MEDIAN:
$22.00
CONSENSUS:
$22.50
UPSIDE:
10.35%
AlphaVal
Deterministic, archetype-aware fair value
Real Estate Investment Trust
85% confidence
Primary model: P/FFO × Healthcare REIT Multiple
Adjust Assumptions
18.0x
$
Key Value Driver
FFO/share ($1.36) × healthcare P/FFO multiple
Implied Market Multiple
15.0x
Plain-Language Summary
At $1.36 FFO/share with a 18x healthcare REIT multiple, the base-case value is $24.45 per share. Dividend yield: 5.9%. DDM cross-check: $22.36.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (29 analysts)
$22.50
Analyst Range
$21.00 – $25.00
Divergence from AlphaVal
9%
Warnings
Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.
Dividend yield of 5.9% is unusually high — make sure the company generates enough cash to keep paying it.
Key Risks
- P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
- Interest rate sensitivity: REIT multiples compress when rates rise
- FFO approximation (NI + D&A) may include gains on property sales — verify